Pearls in Writing · From the Podcast

Lamictal vs Seroquel for Bipolar Depression: The Sprinter and the Marathoner

Bipolar depression is where patients spend most of their suffering — and it is where prescribers most often reach for one of two very different tools: Lamictal (lamotrigine) or Seroquel (quetiapine). They are not substitutes for each other. They run different races.

Two completely different machines

Seroquel is an antipsychotic. It blocks dopamine D2 receptors (dialing down the overactive signaling behind psychosis and mania) and serotonin 5-HT2A receptors. Its breakdown product, norquetiapine, also blocks the norepinephrine transporter — the pump that recycles norepinephrine — which likely contributes its antidepressant punch. Net effect: broad, fast, and sedating.

Lamictal is not an antipsychotic at all. It began life as a seizure medication. It steadies overexcitable brain signaling — blocking sodium channels and reducing release of glutamate, the brain's main "gas pedal" neurotransmitter. Net effect: stabilizing and protective, but slow.

The FDA trap every board exam sets

Here is the pearl students get wrong: Seroquel is FDA-approved for acute bipolar depression. Lamictal is not. Lamictal's bipolar approval is for maintenance — delaying the return of mood episodes, with its strength on the depression side. In practice, Lamictal is used constantly for bipolar depression prevention, and its acute-episode data are mixed (stronger in more severe depression). But if a board question asks which drug is approved to treat the acute episode, the answer is Seroquel. Know the difference between "approved," "evidence-supported," and "commonly used" — exams live in that gap.

Speed vs. staying power

Seroquel works in weeks for an acute depressive episode — and its sedation, a liability elsewhere, doubles as treatment for the insomnia and agitation that ride along with bipolar depression.
Lamictal cannot be rushed. It requires a slow, five-to-six-week dose climb, starting very low. A patient in acute pain gets almost nothing from it in week two. Its value compounds over months: fewer depressive relapses, with a remarkably clean long-term side-effect ledger.

The obstacles that decide it

Seroquel's price is metabolic. Weight gain, blood-sugar and lipid effects, heavy sedation, and morning hangover are the reasons patients quit it — and the reason it is a hard sell for a young patient facing decades of treatment.
Lamictal's price is the rash and the ramp. A serious skin reaction (Stevens-Johnson syndrome) is rare but dangerous, which is exactly why the slow titration exists and why any new rash on Lamictal is a stop-and-call event. Also know its interactions: valproate roughly doubles Lamictal levels (halve the dose), while estrogen-containing birth control cuts Lamictal levels by about half during active-pill weeks — levels can crater, then surge during the placebo week. Pregnancy does the same. This interaction is one of the most tested — and most missed — in all of psychopharmacology.
Seroquel's hidden trap: doses creeping up for "sleep" in patients who were never psychotic or bipolar. Its metabolic cost is a steep price for a sleeping pill.

The bottom line

Acute bipolar depression, suffering now, not sleeping? Seroquel — approved, fast, and sedating on purpose.
The long game — preventing the next depression in a patient worried about weight and metabolic health? Lamictal is the marathoner.
They are frequently partners across time, not rivals: one puts out the fire; the other fireproofs the house.
Never start Lamictal fast, never ignore a rash on it, and never forget the estrogen interaction.

Listen to the full episode: Lamictal (Lamotrigine) vs Seroquel (Quetiapine) for Bipolar Depression — https://pearlsandprep.captivate.fm/episode/inside-the-ring-lamictal-vs-seroquel-a-deep-dive-into-2-of-the-bipolar-depression-heavyweights

Studying for boards or day one with patients? Join Pearls and Prep on Patreon FREE and get the 50 Pearls study guide — 50 high-yield clinical pearls like this one, condensed for quick review: https://www.patreon.com/PearlsandPrep

Pearls and Prep is educational content, not medical advice. All views expressed are exclusively those of NP Z and do not represent any other entity or organization. Perspectives are offered to build conceptual appreciation of psychiatric topics — always rely on current guidelines, primary references, and your own clinical judgment for individual patients.